Le syndrome sérotoninergique : une revue actualisée de la littérature
| Autor: | T. d’Amato, M. Nourredine, Benjamin Rolland, Jean-Michel Dorey, Bruno Mégarbane, L. Jurek |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
business.industry Gastroenterology Cognition Therapeutic education Serotonergic 030226 pharmacology & pharmacy Serotonin syndrome 03 medical and health sciences 0302 clinical medicine Clinical heterogeneity Internal Medicine medicine Drug adverse effect medicine.symptom business Intensive care medicine 030217 neurology & neurosurgery Pharmacogenetics |
| Zdroj: | La Revue de Médecine Interne. 40:98-104 |
| ISSN: | 0248-8663 |
| Popis: | The serotonin syndrome is a potentially deadly complication resulting from drug adverse effect, drug-drug interaction or overdose involving one or more serotonergic molecules, e.g., antidepressants, psychostimulants and sometimes an "ignored" serotonergic compound. The serotonin syndrome typically consists of a clinical triad including cognitive/behavioral, neurovegetative and neuromuscular features. However, this syndrome is characterized by major clinical heterogeneity, making the diagnosis difficult in practice. Moreover, many practitioners are quite unaware of this syndrome. Available scores and classifications can help physicians in their diagnosis approach. Knowing the responsible molecules, their potential interactions and mechanisms of action can help preventing this complication allowing therapeutic education among patients. This updated article reviews the clinical presentation, prevention, management, and pathophysiology of the serotonin syndrome, and addresses the most recent advances in pharmacogenetics regarding this syndrome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect